LIXIL Valuation
Is TJS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of TJS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: TJS (€10.7) is trading above our estimate of fair value (€5.75)
Significantly Below Fair Value: TJS is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for TJS?
Key metric: As TJS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is TJS's PS Ratio? | |
|---|---|
| PS Ratio | 0.3x |
| Sales | JP¥1.49t |
| Market Cap | JP¥508.34b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.7x |
| Enterprise Value/EBITDA | 10x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does TJS's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
FDD Pilkington Deutschland | 1.9x | n/a | €758.9m |
VIB3 Villeroy & Boch | 0.3x | 10.8% | €416.4m |
ST5 STEICO | 0.8x | 9.5% | €277.2m |
WUG Westag | 0.6x | n/a | €117.0m |
TJS LIXIL | 0.3x | 1.9% | €508.3b |
Price-To-Sales vs Peers: TJS is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (0.9x).
Price to Sales Ratio vs Industry
How does TJS's PS Ratio compare vs other companies in the European Building Industry?
| 4 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 4 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: TJS is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Building industry average (0.8x).
Price to Sales Ratio vs Fair Ratio
What is TJS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.3x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: TJS is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €10.70 | €11.20 +4.7% | 9.7% | €14.05 | €10.08 | n/a | 9 |
| Nov ’25 | €10.60 | €11.14 +5.1% | 12.8% | €15.02 | €9.91 | n/a | 9 |
| Oct ’25 | €10.50 | €11.19 +6.6% | 12.8% | €15.09 | €9.96 | n/a | 9 |
| Sep ’25 | €10.60 | €11.19 +5.6% | 12.8% | €15.09 | €9.96 | n/a | 9 |
| Aug ’25 | €10.50 | €11.19 +6.6% | 12.8% | €15.09 | €9.96 | n/a | 9 |
| Jul ’25 | €9.70 | €10.99 +13.3% | 12.7% | €14.73 | €9.72 | n/a | 9 |
| Jun ’25 | €9.95 | €10.98 +10.4% | 12.4% | €14.68 | €9.98 | n/a | 9 |
| May ’25 | €9.90 | €10.77 +8.8% | 5.5% | €11.88 | €10.10 | n/a | 9 |
| Apr ’25 | €11.20 | €12.67 +13.1% | 10.5% | €15.57 | €10.59 | n/a | 8 |
| Mar ’25 | €11.60 | €12.50 +7.7% | 10.5% | €15.36 | €10.45 | n/a | 8 |
| Feb ’25 | €12.00 | €12.46 +3.8% | 11.6% | €15.72 | €10.69 | n/a | 9 |
| Jan ’25 | €11.00 | €12.49 +13.5% | 12.3% | €16.12 | €10.64 | n/a | 9 |
| Dec ’24 | €10.90 | €11.72 +7.6% | 13.1% | €15.28 | €10.09 | n/a | 10 |
| Nov ’24 | €11.00 | €12.12 +10.2% | 11.9% | €15.58 | €10.78 | €10.60 | 10 |
| Oct ’24 | €10.80 | €12.39 +14.7% | 12.5% | €15.82 | €10.95 | €10.50 | 10 |
| Sep ’24 | €11.30 | €12.50 +10.6% | 8.8% | €14.57 | €10.96 | €10.60 | 10 |
| Aug ’24 | €11.30 | €12.90 +14.2% | 7.7% | €14.14 | €11.12 | €10.50 | 10 |
| Jul ’24 | €11.90 | €13.31 +11.9% | 10.1% | €16.51 | €10.99 | €9.70 | 10 |
| Jun ’24 | €12.20 | €14.68 +20.3% | 11.3% | €17.46 | €11.62 | €9.95 | 10 |
| May ’24 | €14.00 | €15.51 +10.8% | 7.8% | €17.32 | €13.99 | €9.90 | 10 |
| Apr ’24 | €14.70 | €16.53 +12.5% | 6.0% | €18.45 | €14.91 | €11.20 | 10 |
| Mar ’24 | €14.60 | €16.41 +12.4% | 8.5% | €19.49 | €14.62 | €11.60 | 11 |
| Feb ’24 | €14.60 | €17.31 +18.6% | 11.9% | €21.91 | €14.84 | €12.00 | 11 |
| Jan ’24 | €13.90 | €17.18 +23.6% | 11.8% | €21.19 | €14.35 | €11.00 | 11 |
| Dec ’23 | €15.10 | €18.28 +21.0% | 12.0% | €22.29 | €15.60 | €10.90 | 10 |
| Nov ’23 | €13.40 | €18.75 +39.9% | 11.5% | €21.78 | €15.25 | €11.00 | 10 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Andritz
€5.2b
Provides plants, equipment, and services for pulp and paper industry, metalworking and steel industries, hydropower stations, and solid/liquid separation in the municipal and industrial sectors in Europe, North America, South America, China, Asia, and internationally.
AZ2
€51.75
7D
0%
1Y
5.3%
Krones
€3.7b
Engages in the planning, development, and manufacture of machines and lines for the production, filling, and packaging technology in Germany and internationally.
KRN
€116.40
7D
0.9%
1Y
13.2%
Finning International
CA$5.2b
Sells, services, and rents heavy equipment, engines, and related products in Canada, Chile, Bolivia, the United Kingdom, Argentina, Ireland, and internationally.
CIH
CA$25.00
7D
-2.3%
1Y
6.8%